We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ENGN market cap is 341.03M. The company's latest EPS is CAD -1.9601 and P/E is -3.38.
| Quarter End | Jul 2023 | Jan 2024 | Apr 2024 |
|---|---|---|---|
| CAD ($) | |||
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -72.1M | -10.77M | -17.31M |
| Net Income | -72.49M | -10.71M | -14.98M |
| Year End 31 October 2023 | 2023 |
|---|---|
| CAD ($) | |
| Total Revenue | 0 |
| Operating Income | -26.06M |
| Net Income | -99.92M |
| Quarter End | Jul 2023 | Jan 2024 | Apr 2024 |
|---|---|---|---|
| CAD ($) | |||
| Total Assets | 7k | 93.42M | 273.53M |
| Total Liabilities | 72.49M | 31.04M | 30.56M |
| Total Equity | -72.48M | 62.39M | 242.97M |
| Year End 31 October 2023 | 2023 |
|---|---|
| CAD ($) | |
| Total Assets | 86.96M |
| Total Liabilities | 14.47M |
| Total Equity | 72.49M |
| Market Cap | 341.03M |
| Price to Earnings Ratio | -3.38 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.15 |
| Price to Book Ratio | 4.66 |
| Dividend Yield | - |
| Shares Outstanding | 50.98M |
| Average Volume (1 week) | 62.19k |
| Average Volume (1 Month) | 192.36k |
| 52 Week Change | -11.97% |
| 52 Week High | 18.40 |
| 52 Week Low | 4.42 |
| Spread (Intraday) | 0.33 (4.79%) |
| Company Name | enGene Holdings Inc |
| Address |
suite 2600, three bentall centre, 595 burrard street vancouver, british columbia V7X 1L3 |
| Website | https://engene.com/ |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
